Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland
Open Access
- 12 June 2013
- journal article
- Published by Springer Science and Business Media LLC
- Vol. 2 (1), 20
- https://doi.org/10.1186/2047-2994-2-20
Abstract
Background The incidence of extended-spectrum beta-lactamase producing-enterobacteriacae (ESBL-E) infection is rising worldwide. We aimed to determine the prevalence and nosocomial acquisition rate of ESBL-E as well as the risk factors for ESBL-E carriage and acquisition amongst patients consecutively admitted to 13 internal medicine units at our hospital who were not previously known to be ESBL-E carriers. Findings We screened all patients admitted or transferred to internal medicine units for ESBL-E on admission and discharge using rectal swabs. Of 1072 patients screened, 51 (4.8%) were carriers of an ESBL-E at admission. Of 473 patients who underwent admission and discharge screening, 21 (4.4%) acquired an ESBL-E. On multivariate analysis, diabetes mellitus without end-organ complications (OR 2.87 [1.09-7.08]), connective tissue disease (OR 7.22 [1.17-44.59]), and liver failure (OR 8.39 [1.55-45.45]) were independent risk factors for carriage of an ESBL-E upon admission to hospital (area under the ROC curve, 0.68). Receipt of a first- or second-generation cephalosporin (OR 9.25 [2.22-37.82]), intra-hospital transfer (OR 6.68 [1.71-26.06]), and a hospital stay >21 days (OR 25.17 [4.18-151.68]) were associated with acquisition of an ESBL-E during hospitalisation; whilst admission from home was protective (OR 0.16 [0.06-0.39]) on univariate regression. No risk profile with sufficient accuracy to predict previously unknown carriage on admission or acquisition of ESBL-E could be developed using readily available patient information. Conclusions ESBL-E carriage is endemic amongst internal medicine patients at our institution. We were unable to develop a clinical risk profile to accurately predict ESBL-E carriage amongst these patients.Keywords
This publication has 26 references indexed in Scilit:
- Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing EnterobacteriaceaePLOS ONE, 2013
- Utility of a Clinical Risk Factor Scoring Model in Predicting Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae on Hospital AdmissionInfection Control & Hospital Epidemiology, 2013
- Burden of Bloodstream Infection Caused by Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae Determined Using Multistate Modeling at a Swiss University Hospital and a Nationwide Predictive ModelInfection Control & Hospital Epidemiology, 2013
- Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital.2009
- Addressing the challenge of extended-spectrum beta-lactamases.2009
- How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisitionAmerican Journal of Infection Control, 2007
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patientsClinical Microbiology & Infection, 2006
- Control of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamase in Intensive Care Units: Rectal Screening May Not Be Needed in Non-Epidemic SituationsInfection Control & Hospital Epidemiology, 2004
- Is Surveillance for Multidrug‐Resistant Enterobacteriaceae an Effective Infection Control Strategy in the Absence of an Outbreak?The Journal of Infectious Diseases, 2002